Senetek Enters into Two Agreements in its Core Areas of Erectile Dysfunction and Skin Care
Business Review Editor
Abstract
Senetek entered an agreement with Douglas Pharmaceuticals to market and distribute Senetek’s premier erectile dysfunction product Invicorp™ in New Zealand. Senetek also entered into an agreement with Shaklee for worldwide licensing, distribution and marketing of Senetek’s Kinetin, a cytokinin used to reduce the signs of ageing.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.